Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$524.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| Aug 12 | SUPN | Supernus Pharmaceuticals,… | MEXER | 1,250 | — | — | +14.7% | Open the original filing on SEC.gov |
| Jul 29 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 1,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | FTAX | 1,450 | $54.73 | $79.4K | -15.0% | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER | 3,000 | — | — | +44.9% | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | FTAX | 1,433 | $54.73 | $78.4K | -17.7% | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER | 3,000 | — | — | +58.7% | Open the original filing on SEC.gov |
| Feb 28 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 28 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | FTAX | 1,279 | $50.69 | $64.8K | -20.0% | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 2,500 | — | — | +64.2% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 500 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 1,125 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 1,524 | $50.86 | $77.5K | -28.1% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 3,000 | — | — | +124.1% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 242 | $50.86 | $12.3K | -9.1% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 500 | — | — | +23.2% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 603 | $51.35 | $31K | -21.8% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 1,125 | — | — | +68.7% | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 22, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL | 11,780 | $44.49 | $524.1K | -90.4% | Open the original filing on SEC.gov |